50767-31-2 Usage
Uses
Used in Pharmaceutical Industry:
[3-(7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentyl]methanol is used as a potential drug candidate for the development of new therapeutic agents. Its unique structure, which includes a heterocyclic ring and an alcohol functional group, makes it a promising molecule for further research and development into potential applications in medicine.
Used in Chemical Intermediates:
In addition to its potential as a drug candidate, [3-(7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentyl]methanol can also be used as a chemical intermediate in the synthesis of other complex organic compounds. Its versatile structure allows for further functionalization and modification, making it a valuable building block in the development of new pharmaceuticals and other specialty chemicals.
Used in Research and Development:
[3-(7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentyl]methanol [3-(7-amino-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentyl]methanol is also utilized in research and development settings, where it can serve as a test molecule for studying various biological and chemical processes. Its unique structure and potential pharmacological properties make it an interesting subject for investigations into drug design, molecular interactions, and other areas of scientific inquiry.
Check Digit Verification of cas no
The CAS Registry Mumber 50767-31-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,7,6 and 7 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 50767-31:
(7*5)+(6*0)+(5*7)+(4*6)+(3*7)+(2*3)+(1*1)=122
122 % 10 = 2
So 50767-31-2 is a valid CAS Registry Number.
50767-31-2Relevant academic research and scientific papers
Dideoxycarbocyclic nucleosides
-
, (2008/06/13)
Antiviral and antitumor compounds are disclosed of general formula: STR1 wherein Z is H, OH or NH2, Y is CH or N, the bond indicated by C1 '--C2 ' is absent or, in combination with the C1 '--C2 ' bond is the unit CH=CH, and X is selected from the group consisting of H, N(R2), SR, OR or halogen, wherein R is H, lower (C1 -C4)alkyl, aryl or mixtures thereof, and the pharmaceutically acceptable salts thereof.
